NexImmune, Inc.
NEXIDelisted Sep 6, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001538210
NexImmune, Inc. was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 13 institutions reported holding it in 13F filings for Q2 2024, worth $408.6K in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in NexImmune, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −7 vs. Q2 2022
- Shares held
- 7.84M
- −462.6K (−5.6%) vs. Q2 2022
- Total value
- $4.34M
- −$9.02M (−67.5%) vs. Q2 2022
- New holders
- 6
- 6 more added
- Sold out
- 13
- 8 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NEXI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 1 | $2.70K |
| Q2 2024 | 13 | $408.6K |
| Q1 2024 | 12 | $858.3K |
| Q4 2023 | 11 | $229.4K |
| Q3 2023 | 31 | $921.4K |
| Q2 2023 | 32 | $1.26M |
| Q1 2023 | 31 | $2.20M |
| Q4 2022 | 29 | $1.45M |
| Q3 2022 | 39 | $4.34M |
| Q2 2022 | 46 | $13.4M |
| Q1 2022 | 52 | $40.1M |
| Q4 2021 | 46 | $47.1M |
| Q3 2021 | 47 | $160.3M |
| Q2 2021 | 42 | $119.0M |
| Q1 2021 | 46 | $184.9M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding NexImmune, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Artal Group S.A. | 1,200,000 | $666.0K | 0.03% | 00.0% | Unchanged |
| ArrowMark Colorado Holdings LLC | 969,029 | $537.0K | 0.01% | −357,014−26.9% | Reduced |
| Slate Path Capital LP | 925,000 | $513.0K | 0.03% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 801,371 | $444.0K | 0.00% | 00.0% | Unchanged |
| Allen Operations LLC | 635,934 | $353.0K | 0.09% | 00.0% | Unchanged |
| FMR LLC | 525,000 | $291.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 473,977 | $263.0K | 0.00% | +27,057+6.1% | Added |
| Bridger Management, LLC | 400,000 | $222.0K | 0.07% | 00.0% | Unchanged |
| EPIQ Capital Group, LLC | 390,600 | $217.0K | 0.11% | 00.0% | Unchanged |
| Kettle Hill Capital Management, LLC | 370,691 | $206.0K | 0.05% | +98,244+36.1% | Added |
| Millennium Management LLC | 161,429 | $90.0K | 0.00% | −19,879−11.0% | Reduced |
| M28 Capital Management LP | 133,442 | $74.0K | 0.08% | 00.0% | Unchanged |
| Brown Brothers Harriman & Co | 122,880 | $68.0K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 111,882 | $62.0K | 0.00% | 00.0% | Unchanged |
| 683 Capital Management, LLC | 100,687 | $56.0K | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 66,214 | $36.0K | 0.00% | −25,000−27.4% | Reduced |
| Geode Capital Management, LLC | 62,956 | $34.0K | 0.00% | 00.0% | Unchanged |
| CAPROCK Group, Inc. | 56,582 | $31.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 50,000 | $28.0K | 0.00% | 00.0% | Unchanged |
| SEI Investments Co | 38,746 | $21.0K | 0.00% | +12,125+45.5% | Added |
| Raymond James & Associates | 30,622 | $17.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 29,343 | $16.0K | 0.00% | −14,601−33.2% | Reduced |
| Rockefeller Capital Management L.P. | 27,860 | $15.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 22,919 | $13.0K | 0.00% | 00.0% | Unchanged |
| Man Group plc | 20,336 | $11.0K | 0.00% | +20,336 | New |
| Susquehanna International Group, LLP | 13,995 | $8.00K | 0.00% | −12,634−47.4% | Reduced |
| Qube Research & Technologies Ltd | 14,049 | $8.00K | 0.00% | −1,797−11.3% | Reduced |
| Tower Research Capital LLC (TRC) | 13,921 | $8.00K | 0.00% | +9,568+219.8% | Added |
| UBS Group AG | 14,624 | $8.00K | 0.00% | +12,075+473.7% | Added |
| Northern Trust Corp | 12,668 | $7.00K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 12,700 | $7.00K | 0.00% | +12,700 | New |
| Smith, Salley & Associates | 11,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| Davenport & Co LLC | 10,500 | $6.00K | 0.00% | +10,500 | New |
| Morgan Stanley | 3,437 | $2.00K | 0.00% | −13,320−79.5% | Reduced |
| BNP Paribas Arbitrage, SA | 1,349 | $748 | 0.00% | +1,349 | New |
| Bank of America Corp | 1 | $0 | 0.00% | −1,046−99.9% | Reduced |
| Wells Fargo & Company | 112 | $0 | 0.00% | +66+143.5% | Added |
| Royal Bank of Canada | 48 | $0 | 0.00% | +48 | New |
| Advisor Group Holdings, Inc. | 150 | $0 | 0.00% | +150 | New |
| Ergoteles LLC | 0 | $0 | 0.00% | −86,200−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −42,321−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −29,084−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −20,285−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Truist Financial Corp | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −10,253−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −1,173−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −1,414−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −669−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −159−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −5−100.0% | Sold out |